Research ArticleOriginal Article
Open Access

Can proliferative hypertrophic scars of the median sternotomy incision predict the occurrence and characteristics of urethral stricture?

Hüseyin Aydemir, Hasan S. Saglam, Salih Budak, Osman Kose and Ahmet Gökçe
Saudi Medical Journal July 2019, 40 (7) 701-706; DOI: https://doi.org/10.15537/smj.2019.7.24285

References

  1. ↵
    1. Baskin LS,
    2. Constantinescu SC,
    3. Howard PS,
    4. McAninch JW,
    5. Ewalt DH,
    6. Duckett JW,
    7. et al.
    (1993) Biochemical characterization and quantitation of the collagenous components of urethral stricture tissue. J Urol 150:642–647.
    OpenUrlPubMedWeb of Science
  2. ↵
    1. Palminteri E,
    2. Berdondini E,
    3. Verze P,
    4. De Nunzio C,
    5. Vitarelli A,
    6. Carmignani L
    (2013) Contemporary urethral stricture characteristics in the developed world. Urology 81:191–196.
    OpenUrl
  3. ↵
    1. Harraz AM,
    2. El-Assmy A,
    3. Mahmoud O,
    4. Elbakry AA,
    5. Tharwat M,
    6. Omar H,
    7. et al.
    (2015) Is there a way to predict failure after direct vision internal urethrotomy for single and short bulbar urethral strictures? Arab J Urol 13:277–281.
    OpenUrl
  4. ↵
    1. Mundy AR,
    2. Andrich DE
    (2011) Urethral strictures. BJU Int 107:6–26.
    OpenUrlPubMed
  5. ↵
    1. Bhavsar S,
    2. Nimigan A,
    3. Hackam DG,
    4. O'Gorman DB,
    5. Gan BS,
    6. Spence JD
    (2009) Keloid scarring, but not Dupuytren's contracture, is associated with unexplained carotid atherosclerosis. Clin Invest Med 32:E95–E102.
    OpenUrlPubMed
  6. ↵
    1. Liao WT,
    2. Yu HS,
    3. Arbiser JL,
    4. Hong CH,
    5. Govindarajan B,
    6. Chai CY,
    7. et al.
    (2010) Enhanced MCP-1 release by keloid CD14+cells augments fibroblast proliferation:role of MCP-1 and Akt pathway in keloids. Exp Dermatol 19:e142–e150.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Border WA,
    2. Noble NA
    (1994) Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286–1292.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Kamath VV,
    2. Krishnamurthy S,
    3. Satelur KP,
    4. Rajkumar K
    (2015) Transforming growth factor-β1 and TGF-β2 act synergistically in the fibrotic pathway in oral submucous fibrosis:An immunohistochemical observation. Indian J Med Paediatr Oncol 36:111–116.
    OpenUrl
  9. ↵
    1. Zhang K,
    2. Chen J,
    3. Zhang D,
    4. Wang L,
    5. Zhao W,
    6. Lin DY,
    7. et al.
    (2018) microRNA expression profiles of scar and normal tissue from patients with posterior urethral stricture caused by pelvic fracture urethral distraction defects. Int J Mol Med 41:2733–2743.
    OpenUrl
  10. ↵
    1. Atiyeh BS
    (2007) Nonsurgical management of hypertrophic scars:evidence-based therapies, standard practices, and emerging methods. Aesthetic Plast Surg 31:468–492.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Jina NH,
    2. Marsh C,
    3. Than M,
    4. Singh H,
    5. Cassidy S,
    6. Simcock J
    (2015) Keratin gel improves poor scarring following median sternotomy. ANZ J Surg 85:378–380.
    OpenUrl
  12. ↵
    1. Li YH,
    2. Yang J,
    3. Liu JQ,
    4. Xie ST,
    5. Zhang YJ,
    6. Zhang W,
    7. et al.
    (2018) A Randomized, placebo-controlled, double-blind, prospective clinical trial of botulinum toxin type A in prevention of hypertrophic scar development in median sternotomy wound. Aesthetic Plast Surg 42:1364–1369.
    OpenUrl
  13. ↵
    1. Sherris DA,
    2. Larrabee WF Jr.,
    3. Murakami CS
    (1995) Management of scar contractures, hypertrophic scars, and keloids. Otolaryngol Clin North Am 28:1057–1068.
    OpenUrlPubMedWeb of Science
  14. ↵
    1. Sproat JE,
    2. Dalcin A,
    3. Weitauer N,
    4. Roberts RS
    (1992) Hypertrophic sternal scars:silicone gel sheet versus Kenalog injection treatment. Plast Reconstr Surg 90:988–992.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Nedelec B,
    2. Shankowsky HA,
    3. Tredget EE
    (2000) Rating the resolving hypertrophic scar:comparison of the Vancouver Scar Scale and scar volume. J Burn Care Rehabil 21:205–212.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Thompson CM,
    2. Sood RF,
    3. Honari S,
    4. Carrougher GJ,
    5. Gibran NS
    (2015) What score on the Vancouver Scar Scale constitutes a hypertrophic scar?Results from a survey of North American burn-care providers. Burns 41:1442–1448.
    OpenUrl
  17. ↵
    1. Li-Tsang CW,
    2. Lau JC,
    3. Chan CC
    (2005) Prevalence of hypertrophic scar formation and its characteristics among the Chinese population. Burns 31:610–616.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Wolfram D,
    2. Tzankov A,
    3. Pülzl P,
    4. Piza-Katzer H
    (2009) Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg 35:171–181.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Truong PT,
    2. Abnousi F,
    3. Yong CM,
    4. Hayashi A,
    5. Runkel JA,
    6. Phillips T,
    7. et al.
    (2005) Standardized assessment of breast cancer surgical scars integrating the Vancouver Scar Scale, short-form McGill pain questionnaire, and patients'perspectives. Plast Reconstr Surg 116:1291–1299.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Jina H,
    2. Simcock J
    (2011) Median sternotomy scar assessment. N Z Med J 124:57–62.
    OpenUrlPubMed
  21. ↵
    1. Child FJ,
    2. Fuller LC,
    3. Higgins EM,
    4. Du Vivier AW
    (1999) A study of the spectrum of skin disease occurring in a black population in south-east London. Br J Dermatol 141:512–517.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    1. Santucci RA,
    2. Joyce GF,
    3. Wise M
    (2007) Male urethral stricture disease. J Urol 177:1667–1674.
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    1. Kinnaird AS,
    2. Levine MA,
    3. Ambati D,
    4. Zorn JD,
    5. Rourke KF
    (2014) Stricture length and etiology as preoperative independent predictors of recurrence after urethroplasty:A multivariate analysis of 604 urethroplasties. Can Urol Assoc J 8:E296–E300.
    OpenUrl
  24. ↵
    1. Ruutu M,
    2. Alfthan O,
    3. Heikkinen L,
    4. Järvinen A,
    5. Lehtonen T,
    6. Merikallio E,
    7. et al.
    (1982) “Epidemic” of acute urethral stricture after open-heart surgery. Lancet 1:218.
    OpenUrlPubMed
  25. ↵
    1. Wilksch J,
    2. Vernon-Roberts B,
    3. Garrett R,
    4. Smith K
    (1983) The role of catheter surface morphology and extractable cytotoxic material in tissue reactions to urethral catheters. Br J Urol 55:48–52.
    OpenUrlPubMedWeb of Science
  26. ↵
    1. Buchholz NP,
    2. Riehmann M,
    3. Gasser TC
    (1993) Absence of urethral strictures with suprapubic urinary drainage during extracorporeal circulation. J Urol 150:337–339.
    OpenUrlPubMed
  27. ↵
    1. Ziyrek M,
    2. Şahin S,
    3. Acar Z,
    4. Şen O
    (2015) The relationship between proliferative scars and endothelial function in surgically revascularized patients. Balkan Med J 32:377–381.
    OpenUrl
  28. ↵
    1. Dustan HP
    (1995) Does keloid pathogenesis hold the key to understanding black/white differences in hypertension severity? Hypertension 26:858–862.
    OpenUrl
  29. ↵
    1. Nacey JN,
    2. Delahunt B
    (1991) Urinary catheter toxicity. N Z Med J 104:355–356.
    OpenUrlPubMed
  30. ↵
    1. Butzelaar L,
    2. Soykan EA,
    3. Galindo Garre F,
    4. Beelen RH,
    5. Ulrich MM,
    6. Niessen FB,
    7. et al.
    (2015) Going into surgery:Risk factors for hypertrophic scarring. Wound Repair Regen 23:531–537.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section